Neural sensitivity following stress predicts anhedonia symptoms: a 2-year multi-wave, longitudinal study.

"code is available at: https://github com/jackie-schwartz/neural_sensitivity_to_stress ."

"Competing interests Over the past 3 years, Dr. Pizzagalli has received consulting fees from Boehringer Ingelheim, Compass Pathways, Engrail Therapeutics, Karla Therapeutics, Neumora Therapeutics (formerly BlackThorn Therapeutics), Neurocrine Biosciences, Neuroscience Software, Otsuka, Sage Therapeutics, Sama Therapeutics, Sunovion, and Takeda; he has received honoraria from the Psychonomic Society and American Psychological Association (for editorial work) and from Alkermes; he has received research funding from the Brain and Behavior Research Foundation, Dana Foundation, Wellcome Leap, Millennium Pharmaceuticals, and NIMH; he has received stock options from Compass Pathways, Engrail Therapeutics, Neumora Therapeutics, and Neuroscience Software. Dr. Auerbach is an unpaid scientific advisor for Ksana Health and a paid scientific advisor for Get Sonar, Inc. No funding from these entities was used to support the current work, and all views expressed are solely those of the authors. All other authors declare no competing interests."

"This project was supported by the Tommy Fuss Fund (RPA, DAP), Dana Foundation (DAP, RPA) and Klingenstein Third Generation Foundation (RPA). DAP (R37MH068376, 5R01MH108602), RPA (R01MH119771, U01MH108168), and DP (R21MH125044) were partially supported by funds from the National Institute of Mental Health. JSK was supported through the Bender-Fishbein Research Award in Child Psychiatry as well as a training fellowship awarded to the Division of Child and Adolescent Psychiatry at Columbia University (T32 MH016434-42). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."